Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXtended CriteriA Treatment for LIver Metastases With Heavy Tumour BURden 1 + 2

NCT04898504 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT04898504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04898504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXtended CriteriA Treatment for LIver Metastases With Heavy Tumour BURden 1 + 2
Lead sponsor
Oslo University Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 23, 2021
Completion date
May 31, 2026
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, colorectal cancer, liver metastases